Skip to main content

1 Result(s)

within Noriko Fujita Remove this filter Medicine & Public Health Remove this filter Internal Medicine Remove this filter Medicine/Public Health, general Remove this filter

and

  1. Article

    Open Access

    Pembrolizumab response in stage IV luminal-type breast cancer with high microsatellite instability: a case report

    Pembrolizumab (PEM), an immune checkpoint inhibitor (ICI), is often used for triple-negative breast cancer, but can also be used to treat solid tumors that exhibit high microsatellite instability (MSI-High). H...

    Keiko Inakami, Noriko Fujita, Chikage Iguchi… in Journal of Medical Case Reports (2024)

    Download PDF (1216 KB) View Article